Sterling Capital Management
KMTS icon

Sterling Capital Management’s Kestra Medical Technologies KMTS Stock Holding History

Sterling Capital Management’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.39K Sell
94
-168
-64% -$3.52K ﹤0.01% 2947
2026
Q1 		$5.22K Buy
262
+38
+17% +$896 ﹤0.01% 2710
2025
Q4 		$5.94K Buy
224
+85
+61% +$2.19K ﹤0.01% 2832
2025
Q3 		$3.3K Buy
139
+68
+96% +$1.22K ﹤0.01% 2892
2025
Q2 		$1.18K Buy
+71
New +$1.55K ﹤0.01% 3036

Other funds holding KMTS

Bain Capital Investors
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AP
Andera Partners Paris $176M AUM 1.8% 1-Year Est. Return
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Eventide Asset Management
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Sterling Capital Management's KMTS Position: Q2 2026 in Review

Sterling Capital Management reduced its Kestra Medical Technologies (KMTS) stake by 64% in Q2 2026, selling an estimated $3.52K and leaving 94 shares worth $2.39K. The position accounts for ﹤0.01% of the portfolio, ranked #2947.

Sterling Capital Management first reported a position in KMTS in Q2 2025 and has held it in 5 quarters since. The position peaked at $5.94K in Q4 2025. 108 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • Sterling Capital Management held 94 shares of Kestra Medical Technologies worth $2.39K as of Q2 2026.
  • Sterling Capital Management sold 168 Kestra Medical Technologies shares in Q2 2026, an estimated $3.52K.
  • Kestra Medical Technologies made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2947 holding.
  • Sterling Capital Management first reported a position in Kestra Medical Technologies in Q2 2025 and has held it in 5 quarters since.
  • Sterling Capital Management's Kestra Medical Technologies position peaked at $5.94K in Q4 2025.
  • 108 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.